Plyushkin/iStock via Getty Images Investment Thesis A recent PTAB ruling consolidated Editas Medicine, Inc.’s (NASDAQ:EDIT) power over foundational CRISPR patents, at least for now. Despite initial market excitement, which saw EDIT rise 9%, the ruling […]
Chip Somodevilla/Getty Images News While the market is promoting excitement for Intel (NASDAQ:INTC) around the potential windfall money from the CHIPS bill, the market is still missing the biggest problem. The chip giant is still […]
Ambrx Biopharma (AMAM) Investor Presentation – Slideshow
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.